CIK 0001022899
- Non-accelerated filer
- Smaller reporting company
Protagenic Therapeutics, Inc.new
Sign in to watch- Ticker
- PTIX
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 061390025
- Phone
- +1 212-994-8200
- Business address
- 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Former names
- Atrinsic, Inc., NEW MOTION, INC., MPLC, Inc., MILLBROOK PRESS INC
- Open-market buys, last 90 days
- $23,756
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$23,756. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2009-06-25 | ZAREF ANDREW Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −200,000 | 0 | ||
| 2009-06-25 | ZAREF ANDREW Chief Financial Officer | Grant or award · Restricted Stock Units | +66,667 | 66,667 | ||
| 2009-06-25 | ZAREF ANDREW Chief Financial Officer | Grant or award · Restricted Stock Units | +200,000 | 200,000 | ||
| 2008-07-14 | ZAREF ANDREW Chief Financial Officer | Grant or award · Options to Purchase Common Stock | +200,000 | 200,000 |
Page 1 of 1 · 4 trades